Study on the Etiology, Risk Factors and Pathogenesis of COPD Based on Clinical Bioinformatics
NCT ID: NCT05069194
Last Updated: 2021-10-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
13000 participants
OBSERVATIONAL
2017-12-10
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The project establishes a cohort of COPD people,high-risk group and the healthy group. The project studys the risk factors, etiology and pathogenesis of COPD. The project studys the interaction between genetic factors and environmental factors on COPD and its effect on pathogenesis, progression and outcome of COPD.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Heterogeneity and Development of Early COPD
NCT06096285
Small Bioactive Molecules in Early COPD Diseases
NCT04950023
Early COPD for China Pulmonary Health Study Stage II
NCT05028985
Predicting Risk Factors for Exacerbation of Chronic Obstructive Pulmonary Disease
NCT03450603
Predictive Value of Inflammatory Biomarkers and FEV1 for COPD
NCT03532893
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COPD
Patients with chronic obstructive pulmonary disease
No interventions assigned to this group
High Risk
People who do not suffer from COPD, but have high risk factor for COPD.
No interventions assigned to this group
Health
People who do not suffer from COPD and do not have a high risk factor for COPD either.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* FEV1 / FVC\< 70% was the diagnostic criterion for COPD after inhaling bronchodilators.
* Over 18 years of age.
* Physical examination and routine laboratory tests were normal.
* Chest CT to exclude other pulmonary diseases.
* Lung function does not meet the diagnostic criteria for COPD.
* having one of the following risk factors: A. Smoking: current smokers, smoking index (number of years of smoking × number of cigarettes per day)≥ L.
B. Biofuel exposure: Subjects frequently use charcoal, wood, and animal dung for home heating and cooking Or crops are defined as having a history of exposure to biofuels. C. Dust and chemical exposure: mining, quarrying, casting, grain dust, paint, chemicals and others (including non-return) In the above categories of self-reported) occupational dust or gas smoke exposure for more than 1 year.
* Over 18 years of age.
* Physical examination and routine laboratory tests were normal.
* Chest CT to exclude other pulmonary diseases.
* Lung function does not meet the diagnostic criteria for COPD.
* No risk factors (including smoking, biofuel exposure, dust or chemical exposure).
Exclusion Criteria
* History of acute lung disease within 3 months.
* History of malignant tumor.
* Pregnant and lactating women.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Zhongshan Hospital
OTHER
The Second Affiliated Hospital of Fujian Medical University
OTHER
The First Affiliated Hospital of Zhengzhou University
OTHER
Xibei Hospital
OTHER
Henan Provincial People's Hospital
OTHER
Shenzhen University
OTHER
Shantou University Medical College
OTHER
Shanghai Minhang Central Hospital
OTHER
Shanghai Fengxian District Central Hospital
OTHER
Sun Med IT(ShangHai) Co. Ltd
UNKNOWN
First Affiliated Hospital of Wenzhou Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ChengShui Chen
Role: STUDY_CHAIR
First Affiliated Hospital of Wenzhou Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The first affiliated hospital of wenzhou medical university
Wenzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
chengshui Chen
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016YFC1304000
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.